This article explores a grouping strategy for therapeutic peptides incorporating theoretical and experimental methodology and results to define a practical and scientifically justified cleaning procedure.
Guy Houser
Advertisement
Guy Houser is an independent consultant.
Articles by Guy Houser
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Blackstone to Provide Pfizer Up to $1.5 Billion for Monthly GLP-1 Berobenatide Development
2
The BioPharm Brief: An AI-Designed Multibody ADC Enters the Clinic, Blackstone Backs Pfizer’s Monthly GLP-1, and enGene Readies a Bladder Cancer BLA
3
enGene Plans Year-End BLA for Detalimogene in BCG-Unresponsive NMIBC
4
FDA Reportedly Pauses National Priority Voucher Pilot and Pauses CRL Publication
5